Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Topical immunotherapy is the best treatment for severe alopecia areata.

Yellow dots are common in severe alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The study concluded that the arachidonic acid pathway and the protein KRT79 play a role in determining the fineness of cashmere.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Topical tofacitinib is effective and safe for treating alopecia areata.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document explains how hair is studied in forensics to identify its source and its role in criminal investigations.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Children and adolescents with allergies tend to have longer eyelashes.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.